There are multiple chapters near you. Select your preferred chapter.

Conduit Pharmaceuticals and Charles River Laboratories have announced a partnership to evaluate AZD1656, a glucokinase activator, in a preclinical model of systemic lupus erythematosus (SLE).

“Not even water?” This is one of the most common questions Muslims receive when fasting during Ramadan. No, we cannot eat or drink while fasting. But Ramadan is the most beautiful and awaited month of ...

You might not know what to say when people ask, "What is lupus?" or "How did you get it?" Dr. Tamar Rubinstein gives clear answers to some of the common questions people with lupus are asked by ...

The Lupus Foundation of America uses an electronic grant submission process. All applicants must submit their full application packages through the ProposalCentral online grants management system.

Join the Lupus Foundation of America's Inaugural TCS New York City Marathon team as we Race to End Lupus on November 2, 2025. Apply now to join LFA's TCS New York City Marathon Team The Lupus ...

Associate Professor, Pathology & Immunology and Medicine, Clinical Track, Washington University School of Medicine, Saint Louis, MO Dr. Kim is an Associate Professor of Medicine at Washington ...

April is a writer and editor who uses her skills to create insightful and compassionate educational materials that help people with lupus and other chronic illnesses. The Lupus Foundation of America ...

“My journey has been anything but ordinary. I’ve faced thyroid cancer, multiple melanomas, and migraines throughout my life. Then, 17 years ago, I was diagnosed with young onset Parkinson’s disease.

We are looking forward to our national education event -- Lupus & You: Answers. Advocacy. Action. This free educational series will bring you the latest in lupus research, disease management, and ...

When your rheumatologist asks you, “Are you getting enough exercise?” what’s your response? For many with lupus, the answer may be “no.” It’s not lack of desire that’s holding people back, though.